Anti-siglec-15 antibody

C - Chemistry – Metallurgy – 12 – N

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

C12N 15/09 (2006.01) A61K 39/395 (2006.01) A61P 1/02 (2006.01) A61P 3/14 (2006.01) A61P 19/08 (2006.01) A61P 19/10 (2006.01) A61P 35/00 (2006.01) A61P 35/04 (2006.01) C07K 16/18 (2006.01) C07K 16/46 (2006.01) C12N 1/15 (2006.01) C12N 1/19 (2006.01) C12N 1/21 (2006.01) C12N 5/10 (2006.01) C12P 21/08 (2006.01)

Patent

CA 2750836

Provided is a pharmaceutical composition for treating and/or preventing abnormal bone metabolism targeting a protein encoded by a gene strongly expressed in osteoclasts. Specifically provided is a pharmaceutical composition containing an antibody which specifically recognizes human Siglec-15 and has an activity of inhibiting osteoclast formation, and the like.

L'invention concerne une composition pharmaceutique destinée à traiter et/ou à prévenir des anomalies du métabolisme osseux, et qui cible une protéine codée par un gène pouvant être exprimé fortement dans des ostéoclastes. L'invention concerne spécifiquement, entre autres, une composition pharmaceutique contenant un anticorps capable de reconnaître spécifiquement une protéine Siglec-15 humaine et qui possède une activité d'inhibition de la formation d'ostéoclastes.

LandOfFree

Say what you really think

Search LandOfFree.com for Canadian inventors and patents. Rate them and share your experience with other people.

Rating

Anti-siglec-15 antibody does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Anti-siglec-15 antibody, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Anti-siglec-15 antibody will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFCA-PAI-O-1918843

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.